CE3F4 – 50 mg

Brand:
Cayman
CAS:
143703-25-7
Storage:
-20
UN-No:
Non-Hazardous - /

Exchange protein activated by cAMP (Epac) proteins mediate cAMP signaling independent of protein kinase A (PKA). CE3F4 is an uncompetitive inhibitor of Epac1 activity toward its effector Rap1 in vitro (IC50 = 23 µM) and in cells.{29533,29532}. It has no effect on PKA activity. CE3F4 blocks Epac1-induced autophagy in cardiomyocytes stimulated with isoprenaline and blocks the activation of transient receptor potential canonical (TRPC) channels by the Epac activator 8-pCPT.{29535,29534}  

 

Available on backorder

SKU: - Category:

Description

An uncompetitive inhibitor of Epac1 activity toward its effector Rap1 in vitro (IC50 = 23 µM) and in cells; has no effect on PKA activity


Formal name: 5,7-dibromo-6-fluoro-3,4-dihydro-2-methyl-1(2H)-quinolinecarboxaldehyde

Synonyms: 

Molecular weight: 351

CAS: 143703-25-7

Purity: ≥98%

Formulation: A crystalline solid


Product Type|Biochemicals|Ion Channel Modulation||Product Type|Biochemicals|Small Molecule Inhibitors||Research Area|Cell Biology|Cell Signaling|cAMP Signaling||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy